Transducin-Like Enhancer of Split 3 (TLE3) expression is associated with taxane sensitivity in non-serous ovarian carcinoma in a three-cohort study

BACKGROUND: Chemo-resistance is a major challenge in ovarian cancer treatment, resulting in poor survival rates. Identifying markers of treatment response is imperative for improving outcome while minimizing unnecessary side effects. We have previously demonstrated that expression of transducin-like...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Epidemiol Biomarkers Prev
Hlavní autoři: Ring, Brian Z., Murali, Rajmohan, Soslow, Robert A., Bowtell, David D.L., Fereday, Sian, deFazio, Anna, Traficante, Nadia, Kennedy, Catherine J, Brand, Alison, Sharma, Raghwa, Harnett, Paul, Samimi, Goli
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984690/
https://ncbi.nlm.nih.gov/pubmed/29531130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-17-1101
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky